BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17623533)

  • 1. Long-term effects of ovulation-stimulating drugs on cancer risk.
    Brinton L
    Reprod Biomed Online; 2007 Jul; 15(1):38-44. PubMed ID: 17623533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer risk after the use of ovulation-stimulating drugs.
    Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
    Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of fertility drugs and risk of ovarian cancer.
    Diergaarde B; Kurta ML
    Curr Opin Obstet Gynecol; 2014 Jun; 26(3):125-9. PubMed ID: 24752005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
    Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
    Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort.
    Brinton LA; Westhoff CL; Scoccia B; Lamb EJ; Trabert B; Niwa S; Moghissi KS
    Hum Reprod; 2013 Oct; 28(10):2813-21. PubMed ID: 23943795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up.
    Kessous R; Davidson E; Meirovitz M; Sergienko R; Sheiner E
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):287-93. PubMed ID: 26337160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulation inducing agents and cancer risk: review of literature.
    Impicciatore GG; Tiboni GM
    Curr Drug Saf; 2011 Sep; 6(4):250-8. PubMed ID: 22129320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term relationship of ovulation-stimulating drugs to breast cancer risk.
    Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Niwa S; Ruggieri D; Trabert B; Lamb EJ
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):584-93. PubMed ID: 24700523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women.
    Lerner-Geva L; Keinan-Boker L; Blumstein T; Boyko V; Olmar L; Mashiach S; Rabinovici J; Potashnik G; Lunenfeld E; Schenker JG; Shushan A; Fishman A; Cohen I; Vagman I; Lunenfeld B
    Breast Cancer Res Treat; 2006 Nov; 100(2):201-12. PubMed ID: 16685587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro fertilization and breast cancer risk: a review.
    Salhab M; Al Sarakbi W; Mokbel K
    Int J Fertil Womens Med; 2005; 50(6):259-66. PubMed ID: 16526416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovulation induction and ovarian malignancy.
    Beltsos AN; Odem RR
    Semin Reprod Endocrinol; 1996 Nov; 14(4):367-74. PubMed ID: 8988531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer and Ovulation Induction Treatments.
    Taheripanah R; Balash F; Anbiaee R; Mahmoodi M; Akbari Sene A
    Clin Breast Cancer; 2018 Oct; 18(5):395-399. PubMed ID: 29628340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers.
    Ayhan A; Salman MC; Celik H; Dursun P; Ozyuncu O; Gultekin M
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1104-11. PubMed ID: 15548140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infertility as a cancer risk factor - a review.
    Cetin I; Cozzi V; Antonazzo P
    Placenta; 2008 Oct; 29 Suppl B():169-77. PubMed ID: 18790330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovulation induction treatment and risk of borderline ovarian tumors.
    Cusidó M; Fábregas R; Pere BS; Escayola C; Barri PN
    Gynecol Endocrinol; 2007 Jul; 23(7):373-6. PubMed ID: 17701767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fertility drugs on cancers other than breast and gynecologic malignancies.
    Brinton LA; Moghissi KS; Scoccia B; Lamb EJ; Trabert B; Niwa S; Ruggieri D; Westhoff CL
    Fertil Steril; 2015 Oct; 104(4):980-988. PubMed ID: 26232746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies.
    Gennari A; Costa M; Puntoni M; Paleari L; De Censi A; Sormani MP; Provinciali N; Bruzzi P
    Breast Cancer Res Treat; 2015 Apr; 150(2):405-13. PubMed ID: 25744295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovulation induction for infertility is it safe or not?
    Anderson SM; Dimitrievich E
    S D J Med; 1996 Nov; 49(11):419-21. PubMed ID: 8973135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood tumor risk after treatment with ovulation-stimulating drugs.
    Brinton LA; Krüger Kjaer S; Thomsen BL; Sharif HF; Graubard BI; Olsen JH; Bock JE
    Fertil Steril; 2004 Apr; 81(4):1083-91. PubMed ID: 15066468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovulation induction and risk of endometrial cancer: a pilot study.
    Benshushan A; Paltiel O; Brzezinski A; Tanos V; Barchana M; Shoshani O; Gordon L; Tsur L; Schenker JG
    Eur J Obstet Gynecol Reprod Biol; 2001 Sep; 98(1):53-7. PubMed ID: 11516800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.